Manifestations cutanées d’un syndrome d’hypersensibilité à l’azathioprine chez un patient atteint d’une maladie de Crohn

Olaiwan, Amani; Wendling, J.; Pouzoulet, J.; Gaulier, A; Ingen‐Housz‐Oro, Saskia; Sigal, M.-L.

doi:10.1016/j.gcb.2008.04.028

Cited by 1 publication

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Azathioprine hypersensitivity syndrome may mimic an acute neutrophilic dermatosis. It is typically reversible on azathioprine cessation [ 1 , 4 ], but subsequent avoidance is crucial as rechallenge can lead to a more severe adverse reaction and even death [ 1 , 6 ]. Therefore, it requires prompt diagnosis and must be distinguished from neutrophilic dermatosis associated with inflammatory bowel disease.…”

Section: Discussionmentioning

confidence: 99%

Azathioprine Hypersensitivity Syndrome: Two Cases of Febrile Neutrophilic Dermatosis Induced by Azathioprine

et al. 2017

View full text Add to dashboard Cite

Background: Azathioprine is an immunosuppressive agent used in the treatment of immune-mediated diseases. Azathioprine hypersensitivity syndrome is a rare adverse reaction occurring a few days to weeks after the administration of azathioprine. Case 1: A 36-year-old male with ulcerative colitis presented with erythematous plaques, pustules and erosions on the lower back, buttocks and thighs associated with high fever (39°C) 2 weeks after the initiation of azathioprine 100 mg/day. Additional findings included leukocytosis (18.6 g/L) with neutrophilia (11.1 g/L) and elevated C-reactive protein (128 mg/L). Histopathology showed a dense infiltrate of neutrophils in the hair follicles. We increased the dose of prednisone to 1 mg/kg/day (60 mg/day) and azathioprine was discontinued. He had marked improvement within 3 weeks and did not have any relapse with a 1-year follow-up. Case 2: A 57-year-old male with ulcerative colitis presented with erythematous plaques and pustules on the lower limbs associated with high fever (40°C) 1 week after the initiation of azathioprine 75 mg/day. Leukocytosis with neutrophilia (13.6 g/L) and elevated C-reactive protein (344 mg/L) were among the laboratory findings. Histopathology showed a dense infiltrate of neutrophils in the hair follicles. The dose of prednisone was increased to 20 mg/day and azathioprine was discontinued, which led to complete remission within 7 days. He did not have any relapse with a 6-month follow-up. Conclusion: The development of acute neutrophilic dermatitis 2 weeks after the initiation of azathioprine and the complete resolution after its withdrawal were in favor of azathioprine hypersensitivity syndrome. It should not be confused with Sweet syndrome associated with inflammatory bowel disease, as maintenance of azathioprine treatment may lead to life-threatening reactions.

show abstract